These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 20211866)
1. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866 [TBL] [Abstract][Full Text] [Related]
2. 'Turning the right screw': targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarction. Möllmann H; Nef HM; Troidl C Cardiovasc Res; 2010 Aug; 87(3):395-6. PubMed ID: 20558440 [No Abstract] [Full Text] [Related]
3. Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion. Hartman MH; Vreeswijk-Baudoin I; Groot HE; van de Kolk KW; de Boer RA; Mateo Leach I; Vliegenthart R; Sillje HH; van der Harst P PLoS One; 2016; 11(12):e0167195. PubMed ID: 27936014 [TBL] [Abstract][Full Text] [Related]
4. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168 [TBL] [Abstract][Full Text] [Related]
5. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction. Takahashi T; Anzai T; Kaneko H; Mano Y; Anzai A; Nagai T; Kohno T; Maekawa Y; Yoshikawa T; Fukuda K; Ogawa S Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1795-804. PubMed ID: 20852043 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction. Daniel LL; Daniels CR; Harirforoosh S; Foster CR; Singh M; Singh K J Am Heart Assoc; 2014 Dec; 3(6):e001286. PubMed ID: 25520329 [TBL] [Abstract][Full Text] [Related]
7. Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction. Jiang Y; Bai J; Tang L; Zhang P; Pu J Cell Physiol Biochem; 2015; 37(3):979-90. PubMed ID: 26393504 [TBL] [Abstract][Full Text] [Related]
8. Augmented early aged neutrophil infiltration contributes to late remodeling post myocardial infarction. Zhong Y; Yu X; Li X; Zhou H; Wang Y Microvasc Res; 2022 Jan; 139():104268. PubMed ID: 34728225 [TBL] [Abstract][Full Text] [Related]
9. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Ikeuchi M; Tsutsui H; Shiomi T; Matsusaka H; Matsushima S; Wen J; Kubota T; Takeshita A Cardiovasc Res; 2004 Dec; 64(3):526-35. PubMed ID: 15537506 [TBL] [Abstract][Full Text] [Related]
11. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction. Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Miyamoto T; Touma M; Sasayama S J Am Coll Cardiol; 2001 Nov; 38(5):1546-53. PubMed ID: 11691538 [TBL] [Abstract][Full Text] [Related]
13. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567 [TBL] [Abstract][Full Text] [Related]
14. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model. Kellar RS; Lancaster JJ; Thai HM; Juneman E; Johnson NM; Byrne HG; Stansifer M; Arsanjani R; Baer M; Bebbington C; Flashner M; Yarranton G; Goldman S J Cardiovasc Pharmacol; 2011 May; 57(5):568-74. PubMed ID: 21326109 [TBL] [Abstract][Full Text] [Related]
16. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974 [TBL] [Abstract][Full Text] [Related]
17. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431 [TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Hattori T; Shimokawa H; Higashi M; Hiroki J; Mukai Y; Tsutsui H; Kaibuchi K; Takeshita A Circulation; 2004 May; 109(18):2234-9. PubMed ID: 15096457 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization. Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]